Ljubljana/HIVbacground

From 2007.igem.org

< Ljubljana(Difference between revisions)
 
(16 intermediate revisions not shown)
Line 3: Line 3:
<title>Company Name</title>
<title>Company Name</title>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1" />
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1" />
-
<link href="http://rokgaber.3host.biz/stylenew_zadaj.css" rel="stylesheet" type="text/css" />
+
<link rel="stylesheet" href="/igem07/index.php?title=User:RGaber/stylesheet/stylenew_zadaj.css&action=raw&ctype=text/css" type="text/css" />
</head>
</head>
<body>
<body>
Line 16: Line 16:
      
      
     </div>
     </div>
-
     <div id="aboutred">
+
     <div align="justify" id="aboutred">
       <h3><span>HIV-1 Infection Background</span></h3>
       <h3><span>HIV-1 Infection Background</span></h3>
-
       <p class="p1"><span><b>HIV primarily infects cells that are important in human immune response: T-cells, macrophages and dendritic cells. By replicating itself in T-cells it destroys them and thus weakens the immune system.</b></span></p>
+
       <p class="p1"><span><b>HIV primarily infects cells that are important in the human immune response: T-cells, macrophages and dendritic cells. By replicating itself in T-cells it destroys them and thus weakens the immune system.</b></span></p>
     </div>
     </div>
   </div>
   </div>
Line 27: Line 27:
-
   <div id="supportingText">
+
   <div align="justify" id="supportingText">
-
Primary infection is the first step in the course of HIV infection. After HIV enters the host cell, it starts replicating itself intensively and is widely disseminated throughout the body, with the lymphoid organs becoming seeded with the virus. There is a significant drop in CD4 T cells at this early time. Flu-like symptoms are common and 50 - 75% of patients develop this acute mononucleosis-like syndrom.<br><br>
+
Primary infection is the first step in the course of HIV infection. After HIV enters the host cell, it starts replicating itself intensively and is widely disseminated throughout the body, with the lymphoid organs becoming seeded with the virus. There is a significant drop in CD4 T cells at this early time. Flu-like symptoms are common and 50 - 75% of patients develop this acute mononucleosis-like syndrome.<br><br>
-
Approximately one to three months after infection a specific immune response develops, causing the number of viral particles to decrease and the CD4 cell count rebounces. However, the immune response is unable to clear the infection completely, and HIV-infected cells persist in the lymph nodes as viral DNA integrated in the host genome. This period of clinical latency may last for as long as 10 years, but there is still a a high level of ongoing viral replication.<br><br>
+
Approximately one to three months after infection a specific immune response develops, causing the number of viral particles to decrease and the CD4 cell count to rebounce. However, the immune response is unable to clear the infection completely and HIV-infected cells persist in the lymph nodes as viral DNA integrated in the host genome. This period of clinical latency may last for as long as 10 years, but there is still a a high level of ongoing viral replication.<br><br>
-
Eventually, clinically apparent diseases develop, such as neoplasms or opportunistic infections. These are a consequence of rapid viral proliferation in CD4 infected cells and their subsequent destruction which weakens the immune system. The onset of these symptoms is known as the progression to AIDS.<br><br>
+
Eventually clinically apparent diseases develop such as neoplasms or opportunistic infections. These are a consequence of rapid viral proliferation in CD4 infected cells and their subsequent destruction which weakens the immune system. The onset of these symptoms is known as the progression to AIDS.<br><br>
-
Despite enormous efforts to find the ultimate cure for AIDS there is no efficient treatment that could totally eliminate HIV. The main reason for not being able to develop a useful drug is the lack of proofreading replication enzymes in HIV. Consequently, mutations occur changing the properties of HIV molecules. Thus, resistance evolves quickly, making many existing drugs useless. Nevertheless, certain therapeutics and drug cocktails can slow down AIDS progression and provide better life for those infected with HIV. Another problem in AIDS treatment is the price of therapeutics; only a fraction of infected population can afford the expensive treatment.
+
<table border="0" style="background:#d0d2fb">
-
<br><br>
+
<tr>
-
<a href="https://static.igem.org/mediawiki/2007/f/f6/HIV_Epidemx3.png">
+
  <td align="justify"> Despite enormous efforts to find the ultimate cure for AIDS there is <b>no efficient treatment that could totally eliminate HIV</b>. The main reason for not being able to develop a useful drug is the lack of proofreading replication enzymes in HIV. Consequently, mutations occur changing the properties of HIV molecules. Thus, resistance evolves quickly, making many existing drugs useless. Nevertheless, certain therapeutics and drug cocktails can slow down AIDS progression and provide a better life for those infected with HIV. Another problem in AIDS treatment is the price of therapeutics; only a fraction of the infected population can afford the expensive treatment.<br><br>  </td>
-
<img border="" src="https://static.igem.org/mediawiki/2007/f/fb/Epidemix_small.jpg" width="677" height="313">
+
  <td> <object width="425" height="355"><param name="movie" value="http://www.youtube.com/v/RO8MP3wMvqg&color1=0xd6d6d6&color2=0xf0f0f0&border=0"></param><param name="wmode" value="transparent"></param><embed src="http://www.youtube.com/v/RO8MP3wMvqg&color1=0xd6d6d6&color2=0xf0f0f0&border=0" type="application/x-shockwave-flash" wmode="transparent" width="354" height="296"></embed></object><br>
-
</a><br>
+
<b>Video:</b> Targeting HIV replication.  </td>
-
<small>
+
  </tr>
-
<b>Adult HIV prevalence at the end of 2005.</b><i> More than 60 % of infected individuals live in Sub-Saharan Africa. South and South-East Asia (especially India) have more than 15 % of infected with HIV.</i>
+
</table>
-
</small>
+
-
<div id="products">
 
-
      <h3><span>Products</span></h3>
 
-
      <p class="p1"><span>Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est <a href="#">Lorem ipsum dolor sit amet.</a></span></p>
 
-
      <p class="p2"><span>Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua.</span></p>
 
-
    </div>
 
-
    <div id="services">
 
-
      <h3><span>Services</span></h3>
 
-
      <p class="p1">Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet <a href="#">clita kasd gubergren, no sea takimata</a> sanctus est Lorem ipsum dolor sit amet. </p>
 
-
      <p class="p2">Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. </p>
 
-
      <p class="p3">Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. </p>
 
-
    </div>
 
-
    <div id="support">
 
-
      <h3><span>Support</span></h3>
 
-
      <p class="p1">Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. </p>
 
-
    </div>
 
-
    <div id="development">
 
-
      <h3><span>Development</span></h3>
 
-
      <p class="p1">Lorem ipsum dolor sit amet, <a href="#">consetetur sadipscing elitr, sed diam nonumy</a> eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. </p>
 
-
      <p class="p2">Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. </p>
 
-
      <p class="p3">Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. </p>
 
-
      <p class="p4">Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. </p>
 
-
      <p class="p5">Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore.</p>
 
-
    </div>
 
 +
 +
 +
 +
 +
 +
     
 +
 +
<br><br><br><br><br><br>
      
      
      
      
     <div id="footer">______________________________________<br />
     <div id="footer">______________________________________<br />
-
     
+
 
 +
<a href="https://2007.igem.org/Ljubljana/AIDSplague">Epidemics</a>     
|<a href="https://2007.igem.org/Ljubljana">Home</a>|
|<a href="https://2007.igem.org/Ljubljana">Home</a>|
-
<a href="https://2007.igem.org/Ljubljana/HIVbacground">HIV-1 Infection Background</a>
+
<a href="https://2007.igem.org/Ljubljana/Currenttreatment">Current Disease Treatment</a>
</div>
</div>
-
 
-
 
   </div>
   </div>
   <div id="linkList">
   <div id="linkList">
     <div id="linkList2">
     <div id="linkList2">
       <div id="lmenu">
       <div id="lmenu">
 +
 +
<center>
 +
<a href="https://2007.igem.org/Ljubljana">
 +
<img border="0" src="https://static.igem.org/mediawiki/2007/c/c6/BlurMetalHome.gif" width="34" height="34">
 +
</center>
 +
 +
 +
         <h3 class="menu"><span><a class="two" href="https://2007.igem.org/Ljubljana/AIDSplague">AIDS - Today's Plague</a></span></h3>
         <h3 class="menu"><span><a class="two" href="https://2007.igem.org/Ljubljana/AIDSplague">AIDS - Today's Plague</a></span></h3>
         <ul>
         <ul>
 +
          <li><a class="one" href="https://2007.igem.org/Ljubljana/AIDSplague">Epidemics</a>&nbsp; </li>
           <li><a class="one" href="https://2007.igem.org/Ljubljana/HIVbacground">HIV-1 Infection Background</a>&nbsp; </li>
           <li><a class="one" href="https://2007.igem.org/Ljubljana/HIVbacground">HIV-1 Infection Background</a>&nbsp; </li>
           <li><a class="one" href="https://2007.igem.org/Ljubljana/Currenttreatment">Current Disease Treatment</a>&nbsp; </li>
           <li><a class="one" href="https://2007.igem.org/Ljubljana/Currenttreatment">Current Disease Treatment</a>&nbsp; </li>
Line 90: Line 82:
       </div>
       </div>
       <div id="llinks">
       <div id="llinks">
-
         <h3 class="links"><span><a class="two" href="https://2007.igem.org/Ljubljana/Strategy">Strategy</a></span></h3>
+
         <h3 class="links"><span><a class="two" href="https://2007.igem.org/Ljubljana/Strategy">Project</a></span></h3>
         <ul>
         <ul>
-
          <li><a class="one" href="https://2007.igem.org/Ljubljana/implementation">Implementation</a>&nbsp; </li>
+
        <li><a class="one" href="https://2007.igem.org/Ljubljana/Strategy">Strategy</a>&nbsp; </li> 
 +
<li><a class="one" href="https://2007.igem.org/Ljubljana/implementation">Implementation</a>&nbsp; </li>
           <li><a class="one" href="https://2007.igem.org/Ljubljana/model">Model</a>&nbsp; </li>
           <li><a class="one" href="https://2007.igem.org/Ljubljana/model">Model</a>&nbsp; </li>
         </ul>
         </ul>
Line 110: Line 103:
         <ul>
         <ul>
-
           <li><a class="one" href="https://2007.igem.org/Ljubljana/achievements">Achievements</a>&nbsp; </li>
+
           <li><a class="one" href="https://2007.igem.org/Ljubljana/summary">Achievements</a>&nbsp; </li>
-
           <li><a class="one" href="https://2007.igem.org/Ljubljana/prospects">Prospects</a>&nbsp; </li>
+
           <li><a class="one" href="https://2007.igem.org/Ljubljana/summary">Prospects</a>&nbsp; </li>
            
            
Line 119: Line 112:
<div id="ldiscussion">
<div id="ldiscussion">
         <h3 class="discussion"><span><a class="two" href="https://2007.igem.org/Ljubljana/team">Team</a></span></h3>
         <h3 class="discussion"><span><a class="two" href="https://2007.igem.org/Ljubljana/team">Team</a></span></h3>
-
         <ul>
+
         <br><br>
-
         
+
</div>        
-
<br><br>
+
 
-
<li><a class="one" href="https://2007.igem.org/Ljubljana/glossary">Glossary</a>&nbsp; </li>
+
<div id="ldiscussion">
 +
<ul><li><a class="one" href="https://2007.igem.org/Ljubljana/glossary">Glossary & References</a>&nbsp; </li>
<li><a class="one" href="https://2007.igem.org/Ljubljana/acknowledgements">Acknowledgements</a>&nbsp; </li>
<li><a class="one" href="https://2007.igem.org/Ljubljana/acknowledgements">Acknowledgements</a>&nbsp; </li>
         </ul>
         </ul>

Latest revision as of 18:40, 23 November 2007

Company Name

HIV-1 Infection Background

HIV primarily infects cells that are important in the human immune response: T-cells, macrophages and dendritic cells. By replicating itself in T-cells it destroys them and thus weakens the immune system.

Primary infection is the first step in the course of HIV infection. After HIV enters the host cell, it starts replicating itself intensively and is widely disseminated throughout the body, with the lymphoid organs becoming seeded with the virus. There is a significant drop in CD4 T cells at this early time. Flu-like symptoms are common and 50 - 75% of patients develop this acute mononucleosis-like syndrome.

Approximately one to three months after infection a specific immune response develops, causing the number of viral particles to decrease and the CD4 cell count to rebounce. However, the immune response is unable to clear the infection completely and HIV-infected cells persist in the lymph nodes as viral DNA integrated in the host genome. This period of clinical latency may last for as long as 10 years, but there is still a a high level of ongoing viral replication.

Eventually clinically apparent diseases develop such as neoplasms or opportunistic infections. These are a consequence of rapid viral proliferation in CD4 infected cells and their subsequent destruction which weakens the immune system. The onset of these symptoms is known as the progression to AIDS.

Despite enormous efforts to find the ultimate cure for AIDS there is no efficient treatment that could totally eliminate HIV. The main reason for not being able to develop a useful drug is the lack of proofreading replication enzymes in HIV. Consequently, mutations occur changing the properties of HIV molecules. Thus, resistance evolves quickly, making many existing drugs useless. Nevertheless, certain therapeutics and drug cocktails can slow down AIDS progression and provide a better life for those infected with HIV. Another problem in AIDS treatment is the price of therapeutics; only a fraction of the infected population can afford the expensive treatment.


Video: Targeting HIV replication.